Lineage Cell Therapeutics, Inc. Common Stock · Purchases of Investments

Latest reported-$33.60Mperiod endingJun 30, 2026

LCTX Purchases of Investments ($0.00 → -$33.60M)

Annual purchases of investments

High-resolution chart · PNG

LCTX purchases of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Purchases of Investments — Annual fiscal periods (USD)
Period ending	Purchases of Investments (USD)
Dec 31, 2025	-14,935,000
Dec 31, 2024	-8,761,000
Dec 31, 2023	-16,403,000
Dec 31, 2022	-53,412,000
Dec 31, 2021	6,024,000
Dec 31, 2020	4,560,000
Dec 31, 2019	-14,215,000
Dec 31, 2018	-8,000
Dec 31, 2017	-189,000
Dec 31, 2016	-748,000
Dec 31, 2015	-1,248,000
Dec 31, 2014	0
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	-3,000,000
Jun 30, 1994	-5,000,000
Jun 30, 1993	-1,900,000
Jun 30, 1992	0